Ajax-Loading

AstraZeneca PLC - Debt To Capital Ratio

AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in Percent.

The item "Debt-To-Capital-Ratio" stands at 40.54 percent as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.

As of the end of AstraZeneca PLC's third quarter, the item "Debt To Capital Ratio" stands at 40.54 Percent. This represents a decrease of -0.84 percentage points compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -2.25 percentage points compared to the value the year prior.
The 1 year change in percentage points is -2.25.
The 3 year change in percentage points is -4.36.

The Serie's long term average value is 43.57 percent. It's latest available value, on 09/30/2025, is 3.03 percentage points lower, compared to it's long term average value.
The Serie's change in percentage points from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0.
The Serie's change in percentage points from it's maximum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is -6.75.

Debt To Capital Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Debt To Capital Ratio905,699,262,464.00
LogoJohnson & Johnson - Debt To Capital Ratio486,508,953,600.00
LogoAbbVie Inc - Debt To Capital Ratio399,570,305,024.00
LogoRoche Holding AG - Debt To Capital Ratio317,433,206,677.55
LogoNovartis AG - Debt To Capital Ratio255,096,620,580.91